*Result*: Respiratory syncytial virus–approved mAb Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors
*Title*:
Respiratory syncytial virus–approved mAb Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors / Julia Ettich, Christoph Wittich, Jens M. Moll, Kristina Behnke, Doreen M. Floss, Jens Reiners, Andreas Christmann, Philipp A. Lang, Sander H. J. Smits, Harald Kolmar, Jürgen Scheller
*Author/editor-in-chief*:
Ettich, Julia (Verfasser) ; Wittich, Christoph (Verfasser) ; Moll, Jens M. (Verfasser) ; Behnke, Kristina (Verfasser) ; Floß, Doreen M. (Verfasser) ; Reiners, Jens (Verfasser) ; Christmann, Andreas (Verfasser) ; Lang, Philipp A. (Verfasser) ; Smits, Sander H. J. (Verfasser) ; Kolmar, Harald (Verfasser) ; Scheller, Jürgen (Verfasser)
*Published in*:
The journal of biological chemistry. - [Amsterdam] : Elsevier B.V., 1905-. - Online-Ressource. - ISSN 1083-351X. - Band 299, Heft 11 (2023), Artikel-ID: 105270
*show_all_articles*
*show_all_articles*
*Publication*:
Bethesda : Elsevier, 2023
*Format*:
*Language*:
*eng*
*DOI*:
10.1016/j.jbc.2023.105270
*oa_rights*:
Open Access
CC BY 4.0
CC BY 4.0